← All trials
NCT06050512
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 2, 2023
- Primary completion
- Oct 31, 2026
- Completion date
- Oct 31, 2026
- First posted
- Sep 22, 2023
- Last posted
- Nov 7, 2023
- Enrollment
- 34
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of PittsburghLead sponsor
- University of PittsburghSponsor investigator
- University of PittsburghOverall official - principal investigator
- University of PittsburghOfficial
- Bristol-Myers SquibbCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.